Correlation Between Anebulo Pharmaceuticals and Belite Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Belite Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Belite Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Belite Bio ADR, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Belite Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Belite Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Belite Bio.

Diversification Opportunities for Anebulo Pharmaceuticals and Belite Bio

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Anebulo and Belite is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Belite Bio ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Belite Bio ADR and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Belite Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Belite Bio ADR has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Belite Bio go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and Belite Bio

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Belite Bio. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 1.1 times less risky than Belite Bio. The stock trades about -0.16 of its potential returns per unit of risk. The Belite Bio ADR is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  6,779  in Belite Bio ADR on August 29, 2024 and sell it today you would lose (35.00) from holding Belite Bio ADR or give up 0.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Anebulo Pharmaceuticals  vs.  Belite Bio ADR

 Performance 
       Timeline  
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Belite Bio ADR 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Belite Bio ADR are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Belite Bio exhibited solid returns over the last few months and may actually be approaching a breakup point.

Anebulo Pharmaceuticals and Belite Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anebulo Pharmaceuticals and Belite Bio

The main advantage of trading using opposite Anebulo Pharmaceuticals and Belite Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Belite Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Belite Bio will offset losses from the drop in Belite Bio's long position.
The idea behind Anebulo Pharmaceuticals and Belite Bio ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges